Contribution of in vitro NMR spectroscopy to metabolic and neurodegenerative disorders;Apports de la spectroscopie par résonance magnétique nucléaire des fluides dans l'étude de maladies métaboliques et neurodégénératives

Revue Neurologique

Volumn 163, Issue 10, 2007, Pages 960-965

  Mochel, F ^a   Barritault, J ^b   Boldieu, N ^b   Eugene M ^b   Sedel, F ^a   Durr, A ^a   Seguin, F ^b  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b POITIERS UNIVERSITY HOSPITAL   (France)

Author keywords

Cerebrospinal fluid; Inborn errors of metabolism; Inherited metabolic diseases; Nuclear magnetic resonance; Spectroscopy

Indexed keywords

CEREBROSPINAL FLUID ANALYSIS; DEGENERATIVE DISEASE; GENETIC SCREENING; HUMAN; IN VITRO STUDY; METABOLIC DISORDER; MULTIVARIATE ANALYSIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; REVIEW;

EID: 36248933271     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0035-3787(07)92640-5     Document Type: Article

References (35)

1. BURNS SP, HOLMES HC, CHALMERS RA, JOHNSON A, ILES RA. (1998). Proton NMR spectroscopic analysis of multiple acyl-CoA dehydrogenase deficiency - capacity of the choline oxidation pathway for methylation in vivo. Biochim Biophys Acta, 1406: 274-282.
2. BURNS SP, WOOLF DA, LEONARD JV, ILES RA. (1992). Investigation of urea cycle enzyme disorders by 1H-NMR spectroscopy. Clin Chim Acta, 209: 47-60.
3. CALDEIRA ARAÚJO H, SMIT W, VERHOEVEN NM et al. (2005). Guanidinoacetate methyltransferase deficiency identified in adults and a child with mental retardation. Am J Med Genet A, 133: 122-127.
4. ENGELKE UF, LIEBRAND-VAN SAMBEEK ML, DE JONG JG, LEROY JG, MORAVA E, SMEITINK, WEVERS RA. (2004). N-acetylated metabolites in urine: proton nuclear magnetic resonance spectroscopic study on patients with inborn errors of metabolism. Clin Chem, 50: 58-66.
5. ENGELKE UF, TANGERMAN A, WILLEMSEN MA, MOSKAU D, LOSS S, MUDD SH, WEVERS RA. (2005). Dimethyl sulfone in human cerebrospinal fluid and blood plasma confirmed by one-dimensional (1)H and two-dimensional (1)H-(13)C NMR. NMR Biomed, 18: 331-336.
6. GARTLAND KP, BEDDELL CR, LINDON JC, NICHOLSON JK. (1991). Application of pattern recognition methods to the analysis and classification of toxicological data derived from proton nuclear magnetic resonance spectroscopy of urine. Mol Pharmacol, 39: 629-642.
7. GUERRINI M, NAGGI A, GUGLIERI S, SANTARSIERO R, TORRI G. (2005). Complex glycosaminoglycans: profiling substitution patterns by two-dimensional nuclear magnetic resonance spectroscopy. Anal Biochem, 337: 35-47.
8. HAUET T, BAUMERT H, GIBELIN H, HAMEURY F, GOUJON JM, CARRETIER M, EUGENE M. (2000). Noninvasive monitoring of citrate, acetate, lactate, and renal medullary osmolyte excretion in urine as biomarkers of exposure to ischemic reperfusion injury. Cryobiology, 41: 280-291.
9. HOLMES E, TSANG TM, TABRIZI SJ. (2006). The application of NMR-based metabonomics in neurological disorders. NeuroRx, 3: 358-372.
10. HUCK JH, VERHOEVEN NM, STRUYS EA, SALOMONS GS, JAKOBS C, VAN DER KNAAP MS. (2004). Ribose-5-phosphate isomerase deficiency: new inborn error in the pentose phosphate pathway associated with a slowly progressive leukoencephalopathy. Am J Hum Genet, 74: 745-751.
11. ILES RA, CHALMERS RA, HIND AJ. (1986). Methylmalonic aciduria and propionic acidaemia studied by proton nuclear magnetic resonance spectroscopy. Clin Chim Acta, 161: 173-189.
12. ILES RA, HIND AJ, CHALMERS RA. (1985). Use of proton nuclear magnetic resonance spectroscopy in detection and study of organic acidurias. Clin Chem, 31: 1795-1801.
13. KLEEFSTRA T, ROSENBERG EH, SALOMONS GS, STROINK H, VAN BOKHOVEN H, HAMEL BC, DE VRIES BB. (2005). Progressive intestinal, neurological and psychiatric problems in two adult males with cerebral creatine deficiency caused by an SLC6A8 mutation. Clin Genet, 68: 379-381.
14. LEHNERT W, HUNKLER D. (1986). Possibilities of selective screening for inborn errors of metabolism using high-resolution 1H-FT-NMR spectrometry. Eur J Pediatr, 145: 260-266.
15. LUTZ NW, MAILLET S, NICOLI F, VIOUT P, COZZONE PJ. (1998). Further assignment of resonances in 1H NMR spectra of cerebrospinal fluid (CSF). FEBS Lett, 425: 345-351.
16. LUTZ NW, VIOLA A, MALIKOVA I, CONFORT-GOUNY S, RANJEVA JP, PELLETIER J, COZZONE PJ. (2007). A branched-chain organic acid linked to multiple sclerosis: First identification by NMR spectroscopy of CSF. Biochem Biophys Res Commun, 354: 160-164.
17. MOCHEL F, CHARLES P, SEGUIN F et al. (2007). Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression. PLoS ONE, 2:e647.
18. MOOLENAAR SH, GOHLICH-RATMANN G, ENGELKE UF et al. (2001). Beta-ureidopropionase deficiency: a novel inborn error of metabolism discovered using NMR spectroscopy on urine. Magn Reson Med, 46: 1014-1017.
19. MOOLENAAR SH, POGGI-BACH J, ENGELKE UF et al. (1999). Defect in dimethylglycine dehydrogenase, a new inborn error of metabolism: NMR spectroscopy study. Clin Chem, 45: 459-464.
20. MOOLENAAR SH, VAN DER KNAAP MS, ENGELKE UF et al. (2001). In vivo and in vitro NMR spectroscopy reveal a putative novel inborn error involving polyol metabolism. NMR Biomed, 14: 167-176.
21. NICHOLSON JK, CONNELLY J, LINDON JC, HOLMES E. (2002). Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov, 1: 153-161.
22. NICHOLSON JK, LINDON JC, HOLMES E. (1999). "Metabonomics": understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data. Xenobiotica, 29: 1181-1189.
23. RENEMA WK, SCHMIDT A, VAN ASTEN JJ et al. (2003). MR spectroscopy of muscle and brain in guanidinoacetate methyltransferase (GAMT)-deficient mice: validation of an animal model to study creatine deficiency. Magn Reson Med, 50: 936-943.
24. SASS JO, MOHR V, OLBRICH H et al. (2006). Mutations in ACY1, the gene encoding aminoacylase 1, cause a novel inborn error of metabolism. Am J Hum Genet, 78: 401-409.
25. SCHULZE A. (2003). Creatine deficiency syndromes. Mol Cell Biochem, 244: 143-150.
26. SCHULZE A, BACHERT P, SCHLEMMER H et al. (2003). Lack of creatine in muscle and brain in an adult with GAMT deficiency. Ann Neurol, 53: 248-251.
27. SEWELL AC, MURPHY HC, ILES RA. (2002). Proton nuclear magnetic resonance spectroscopic detection of sialic acid storage disease. Clin Chem, 48: 357-359.
28. SHAPIRO MJ, GOUNARIDES JS. (2000). High resolution MAS-NMR in combinatorial chemistry. Biotechnol Bioeng, 71: 130-148.
29. TSANG TM, WOODMAN B, MCLOUGHLIN GA, GRIFFIN JL, TABRIZI SJ, BATES GP, HOLMES E. (2006). Metabolic characterization of the R6/2 transgenic mouse model of Huntington's disease by high-resolution MAS 1H NMR spectroscopy. J Proteome Res, 5: 483-492.
30. UNDERWOOD BR, BROADHURST D, DUNN WB et al. (2006). Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles. Brain, 129: 877-886.
31. VAN COSTER RN, GERLO EA, GIARDINA TG et al. (2005). Aminoacylase I deficiency: a novel inborn error of metabolism. Biochem Biophys Res Commun, 338: 1322-1326.
32. WEVERS RA, ENGELKE U, WENDEL U, DE JONG JG, GABREELS FJ, HEERSCHAP A. (1995). Standardized method for high-resolution 1H-NMR of cerebrospinal fluid. Clin Chem, 41: 744-751.
33. WEVERS RA, ENGELKE UF, MOOLENAAR SH et al. (1999). 1H-NMR spectroscopy of body fluids: inborn errors of purine and pyrimidine metabolism. Clin Chem, 45: 539-548.
34. WILD EJ, TABRIZI SJ. (2006). Predict-HD and the future of therapeutic trials. Lancet Neurol, 5: 724-725.
35. WOLF NI, WILLEMSEN MA, ENGELKE UF et al. (2004). Severe hypomyelination associated with increased levels of N-acetylaspartylglutamate in CSF. Neurology, 62: 1503-1508.